What role can olive oil play in a diet when metabolic dysfunction-associated steatotic liver disease (MASLD) is present?
The most scientifically interesting answer does not begin with an individual bottle, but with the overall dietary pattern.
Current European guidelines on MASLD explicitly recommend improving the quality of one’s diet, similar to the Mediterranean dietary pattern. Olive oil is one of the characteristic fat sources of this pattern.
Human studies specifically on olive oil also provide interesting results. For example, individual randomized trials report more favorable changes in liver fat or other metabolic parameters. At the same time, a meta-analysis of seven randomized trials published in 2024 shows that the overall evidence for an independent, liver-specific effect of olive oil is not yet conclusive.
The positive and scientifically sound statement is therefore: Olive oil can be a high-quality fat source within a Mediterranean-oriented dietary pattern, which is explicitly taken into account in current MASLD guidelines.
However, olive oil is not a treatment for MASLD. Even a particularly high polyphenol content does not automatically turn a premium olive oil into a food that "reduces" a fatty liver.
In this Green Agora guide, we therefore take a close look at guidelines, randomized human studies, Mediterranean diets, liver fat, weight management, polyphenols, and the question of what can actually be derived from this in practical and legal terms.
Status of scientific and regulatory classification: September 2026.
Ayhan from Green Agora
Olive oil and fatty liver | The most important answers first
| Can olive oil cure MASLD? | No. Olive oil is a food and not an approved treatment or cure for MASLD. |
| Can olive oil be part of a diet for MASLD? | Yes. Current European guidelines recommend a dietary quality similar to the Mediterranean dietary pattern. Olive oil is one of the characteristic fat sources of this pattern. |
| What do olive oil studies show? | Individual human studies report positive changes, including those in liver fat or metabolic parameters. However, the overall evidence is heterogeneous. |
| What is particularly important in MASLD? | Depending on the initial situation, especially dietary quality, sustainable weight management, physical activity, fewer ultra-processed foods, and the treatment of cardiometabolic risk factors. |
| Is high-phenolic olive oil better for the liver? | There is currently no sufficiently robust clinical evidence to support the assumption that a high total polyphenol value provides an additional liver-specific benefit in MASLD. |
| Is 20 g of olive oil a "liver dose"? | No. The well-known 20 g specification is part of the conditions for the EU health claim for certain olive oil polyphenols and is not a MASLD dosage. |
| What is the most important practical point? | Integrate olive oil as a fat source into a high-quality dietary pattern, rather than consuming it in addition like a supplement or medication. |
NAFLD is now called MASLD | Why the name has changed
Many older studies still use the terms:
NAFLD | Non-Alcoholic Fatty Liver Disease
and:
NASH | Non-Alcoholic Steatohepatitis.
Since an international consensus in 2023, a new nomenclature has been used.
The overarching term is:
SLD | Steatotic Liver Disease.
The former NAFLD is largely being replaced by:
MASLD | Metabolic Dysfunction-Associated Steatotic Liver Disease
For MASLD, hepatic steatosis and at least one defined cardiometabolic risk factor must be present. Classification also takes alcohol consumption into account, as other categories such as MetALD may become relevant at higher alcohol levels within the new SLD nomenclature.
These include, for example, criteria related to:
- Overweight or obesity
- Glucose metabolism or diabetes
- Blood pressure
- Triglycerides
- HDL cholesterol
The former NASH is now also referred to as:
MASH | Metabolic Dysfunction-Associated Steatohepatitis.
The new terminology clarifies an important point:
MASLD is closely linked to the entire metabolism and is not merely an isolated accumulation of fat in the liver.
What is MASLD?
In steatotic liver disease, there is an increased accumulation of fat in the liver.
In MASLD, this steatosis occurs together with at least one cardiometabolic risk factor.
The disease encompasses a spectrum.
In some people, the primary condition is steatosis.
In some cases, additional changes may occur, such as:
- Inflammation
- Liver cell damage
- Fibrosis
- Cirrhosis
Not everyone with MASLD automatically develops advanced liver disease.
Precisely for this reason, assessing individual fibrosis risk is medically important.
At the same time, cardiometabolic diseases such as type 2 diabetes, obesity, high blood pressure, and lipid metabolism disorders play an important role.
How common is a fatty liver?
When stating prevalence, a distinction must now be made between older NAFLD data and the new MASLD definition.
The German DGVS guideline from 2022 estimated the prevalence of the then-named NAFLD in Germany at approximately:
23 percent of the adult population.
This magnitude shows how common steatotic liver diseases are.
However, the figure should not be adopted as the current MASLD prevalence without further consideration, as diagnostic criteria have also changed with the new nomenclature.
Regardless of the exact definition, MASLD is now one of the most common chronic liver diseases.
Why MASLD can go unnoticed for a long time
MASLD can cause few or no specific symptoms for a long time.
Steatosis is therefore often discovered during the course of other examinations.
For example:
- during an ultrasound examination
- through abnormal laboratory values
- as part of a metabolic workup
Current European guidelines recommend a structured assessment of fibrosis risk for risk groups.
For this purpose, blood-based tests such as the:
FIB-4 score
can be used as a starting point.
Depending on the result, further procedures such as:
transient elastography
may be relevant.
Of course, advice on olive oil cannot replace such a medical risk assessment.
What current European guidelines recommend for MASLD
The 2024 EASL-EASD-EASO guidelines clearly place lifestyle interventions at the center of MASLD management.
These include in particular:
- Improving dietary quality
- Sustainable weight management if overweight
- Regular physical activity
- Fewer ultra-processed foods
- Avoidance of sugar-sweetened beverages
- Recording and, if necessary, reducing alcohol consumption; complete abstinence is recommended in cases of advanced fibrosis or cirrhosis
- Treatment of cardiometabolic comorbidities
Regarding diet, the guidelines explicitly recommend a quality:
similar to the Mediterranean dietary pattern.
This pattern is characterized by, among other things:
- Olive oil
- Vegetables
- Fruit
- Nuts and seeds
- Legumes
- Whole grain products
- Fish and seafood
At the same time, sugar, refined carbohydrates, large amounts of saturated fatty acids, ultra-processed foods, and processed meat are reduced.
Thus, olive oil has a justifiable place within the dietary pattern described by the guidelines – without becoming a MASLD medication itself.
Weight management | One of the best-proven factors in MASLD
For people with MASLD and excess weight, the European guidelines state concrete target ranges.
A sustained weight loss of:
at least 5 percent
is associated with a reduction in liver fat.
A reduction of:
7 to 10 percent
is cited as the target range for improving liver inflammation.
At:
at least 10 percent
there is the best evidence for improvements in fibrosis.
These target ranges are not a general personal weight loss instruction for everyone.
However, they show very clearly that:
In MASLD, sustainable weight management has significantly stronger clinical evidence than the search for a single "liver superfood."
Exercise | Another clear component of MASLD management
Physical activity is also explicitly recommended in the European guidelines.
The following are mentioned as preferred guidance:
more than 150 minutes of moderate physical activity per week
or:
75 minutes of higher-intensity physical activity.
The specific form should be adapted to individual possibilities, health conditions, and preferences.
Exercise can also reduce liver steatosis and shows once again why MASLD should not be reduced to the choice of a single food.
Where does olive oil come into play?
Olive oil is a characteristic fat source of the Mediterranean dietary pattern.
It is therefore situated precisely within a dietary context that current European MASLD guidelines explicitly name as a guide for better dietary quality.
Typically, olive oil is combined with foods such as:
- Vegetables
- Legumes
- Whole grain products
- Nuts and seeds
- Fish
- Salads
- Other minimally processed plant-based foods
At the same time, it is not about consuming as much olive oil as possible on top of everything else.
Olive oil is a building block of the Mediterranean dietary pattern – not its entire explanation.
Why extra virgin olive oil is nutritionally interesting
Extra virgin olive oil possesses several properties that make it nutritionally interesting.
Its fatty acid profile is typically dominated by:
oleic acid.
Oleic acid is a monounsaturated fatty acid.
Extra virgin olive oil also contains natural accompanying substances such as:
- phenolic compounds
- tocopherols
- sterols
- aromatic compounds
It is precisely this combination of fatty acid profile and natural accompanying substances that is one reason why extra virgin olive oil is being intensively studied scientifically.
The crucial question for this article, however, is:
What results are actually seen in humans with MASLD?
What randomized olive oil studies show regarding liver fat
There are indeed randomized human studies with interesting positive results.
A study involving 66 people with a former NAFLD diagnosis compared:
20 g of olive oil per day
with:
20 g of sunflower oil per day.
The intervention lasted twelve weeks.
Both groups simultaneously received a calorie-reduced diet.
In both groups, parameters decreased, including:
- Body weight
- Waist circumference
- Blood pressure
- Sonographically determined degree of liver fat accumulation
The decrease in the sonographically determined degree of fatty liver was greater in the olive oil group in this study.
This is a positive randomized human result and may be reported as such.
However, three important points remain for scientific classification:
- The study was relatively small, with 66 participants.
- It lasted twelve weeks.
- Both groups simultaneously received a calorie-reduced diet.
Therefore, it does not prove that 20 g of olive oil treats MASLD independently of the rest of the dietary context.
Another randomized study within a calorie-reduced diet
Another study included 50 people with former NAFLD.
Here, too, the participants received a:
calorie-reduced diet.
One group received a larger proportion of their daily energy from olive oil.
After twelve weeks, changes were observed in:
- ALT
- AST
- sonographically assessed steatosis
This study also provides an interesting positive signal for olive oil within a structured dietary intervention.
However, the olive oil intake and weight reduction took place simultaneously.
Thus, the effect of the individual food cannot be completely separated from the entire dietary concept.
PREDIMED | Mediterranean diet with EVOO and liver fat
The liver was also investigated within the well-known PREDIMED research program.
One sub-study looked at older people with high cardiovascular risk.
Comparisons included, among others:
- Mediterranean diet supplemented with extra virgin olive oil
- Mediterranean diet supplemented with nuts
- a control diet
After several years of observation, the prevalence of hepatic steatosis was lower in the EVOO group.
The average measured liver fat content was also numerically lower.
This is another interesting signal.
However, it remains a study on a:
Dietary pattern.
It does not prove that a specific amount of a single high-phenolic olive oil treats MASLD as an isolated therapy.
2024 | Meta-analysis of randomized olive oil studies
For an overall assessment, a systematic review with meta-analysis published in 2024 is particularly important.
It included:
7 randomized controlled trials with a total of 515 individuals.
Compared to the respective control interventions, the analysis showed:
no statistically significant overall effect on ALT.
Also for:
AST
no significant overall effect was found.
In terms of BMI, however, there was a small, statistically significant difference in favor of the olive oil interventions.
Overall, the authors described a moderately positive or modest influence on body weight, but not a clear overall effect on the liver enzymes studied.
This is crucial for classification.
Individual studies provide interesting positive results.
However, the combined analysis of several randomized studies shows:
An independent, liver-specific effect of olive oil has not yet been consistently proven to a degree that would warrant a general therapeutic statement.
What we can actually conclude from the olive oil studies
The scientific situation is neither:
"Olive oil is proven to work against fatty liver."
nor:
"Olive oil plays no interesting role at all."
The evidence lies in between.
We have:
- randomized human studies with positive individual results
- studies of Mediterranean dietary patterns with EVOO
- different amounts of olive oil and comparison interventions
- different methods for measuring liver fat
- frequently occurring concurrent weight loss
- a meta-analysis with no significant overall effect on ALT and AST
The scientifically robust overall statement is therefore: Olive oil is a well-studied component of high-quality dietary patterns for MASLD. Individual studies show positive signals, but an independent therapeutic effect of olive oil on MASLD is not yet sufficiently proven.
2025 | Mediterranean and low-fat diets improved MASLD
A randomized study from 2025 examined 250 adults with MASLD and a BMI of at least 25.
For twelve weeks, they received either a:
moderately calorie-reduced Mediterranean diet
or a:
moderately calorie-reduced low-fat diet.
In both groups, body weight, liver steatosis, and liver stiffness improved.
However, no significant difference was found between the two dietary forms for the core parameters examined.
This does not mean the Mediterranean diet was ineffective.
On the contrary:
It was effective – but the low-fat calorie-reduced diet was also effective under these study conditions.
The study thus underscores the importance of a structured diet and weight reduction.
2026 | Weight loss and fewer ultra-processed foods continue to move into focus
In 2026, another randomized study involving people with MASLD and overweight or obesity was published.
Over six months, the following were compared:
- a Mediterranean diet
- a lower-carbohydrate and higher-protein diet
- general nutritional recommendations
There was no significant direct difference between the assigned dietary forms in the change in measured liver fat.
Of particular relevance, however, were changes in:
- body weight or BMI
- consumption of ultra-processed foods
These factors were significantly associated with the improvement of liver fat.
The study thus strengthens the idea of a flexible, long-term feasible, and patient-centered nutritional approach.
For practice, this is an important finding:
The best nutritional strategy is not necessarily the one with the most spectacular name, but a high-quality strategy that can be implemented over the long term.
Why the Mediterranean diet nevertheless remains a strong option
The Mediterranean diet remains a dietary strategy explicitly considered by European MASLD guidelines.
Its strength lies in the fact that it does not just look at a single liver measure.
It combines:
- a favorable selection of plant-based foods
- high-quality fat sources
- fiber intake
- fewer ultra-processed foods
- less sugar and refined carbohydrates
- an overall cardiometabolically relevant nutritional context
Olive oil fits into this pattern as a characteristic plant-based fat source.
However, "Mediterranean" does not mean adding as much olive oil as possible to every meal.
It means:
understanding the entire dietary pattern.
Olive oil and polyphenols | Why the research is exciting
Polyphenols are among the natural minor components that make extra virgin olive oil scientifically particularly interesting.
Depending on the olive variety, degree of ripeness, processing, harvest, and storage, various phenolic compounds can be present.
These include, for example:
- hydroxytyrosol and its derivatives
- tyrosol and its derivatives
- oleocanthal
- oleacein
- other secoiridoids and phenolic compounds
In cell and animal models, various biological processes are investigated, including those related to:
- oxidative processes
- inflammatory signaling pathways
- lipid metabolism
- insulin signaling
This research is an important reason why phenol-rich olive oils are so scientifically interesting.
However, their level of evidence must be correctly named.
A plausible mechanism in a cell culture or an animal model is not yet clinical proof that a specific olive oil treats MASLD in humans.
What human studies on olive oil polyphenols show
Olive oils with different phenol contents have also been studied in humans.
Studies here look at parameters related to, among other things:
- oxidized LDL
- blood pressure
- inflammatory markers
- various cardiometabolic parameters
Thus, there is indeed interesting human research on different phenolic profiles of olive oil.
However, these studies do not automatically answer the specific MASLD question:
Does a high-phenolic EVOO reduce liver fat in humans more than a suitable EVOO with a lower phenol content?
For such a general clinical statement, sufficiently robust direct evidence is currently lacking.
Polyphenols in olive oil | Taste, analytical values, and EU Health Claim
A small oleocanthal study | An interesting human signal
Oleocanthal has also been studied in connection with hepatic steatosis.
One study included 23 people with metabolic syndrome and liver steatosis.
They received an extra virgin olive oil with a high oleocanthal concentration daily for two months.
After the intervention, changes were observed in, among other things:
- body weight
- waist circumference
- ALT
- Fatty Liver Index
- various inflammatory markers
This is an interesting signal from a human intervention and justifies further research.
However, the methodological limitations are significant.
The study had only 23 participants and no parallel control group.
Additionally, body weight decreased.
Therefore, it cannot be reliably determined what proportion of the observed changes was specifically attributable to oleocanthal or the olive oil studied.
The study makes oleocanthal scientifically interesting, but does not justify a treatment claim for MASLD.
2025 Review | EVOO for MASLD remains an interesting field of research
A review published in 2025 evaluated numerous studies on extra virgin olive oil and MASLD.
Overall, the authors describe:
promising indications, particularly in connection with a Mediterranean diet.
At the same time, they name significant limitations of the evidence to date:
- heterogeneous study designs
- different olive oils
- different dosages
- different endpoints
- partly small studies
- too few high-quality long-term randomized studies
The appropriate conclusion is therefore:
EVOO and MASLD are a relevant field of research – but a therapeutic effect of high-phenolic olive oils cannot yet be generally derived from this.
The EU Health Claim for olive oil polyphenols
For certain olive oil polyphenols, there is an expressly approved health claim by the European Union.
It states:
Olive oil polyphenols contribute to the protection of blood lipids from oxidative stress.
The claim may only be used for olive oil that contains at least:
5 mg of hydroxytyrosol and its derivatives, for example oleuropein complex and tyrosol, per 20 g of olive oil.
In addition, consumers must be informed that the positive effect is achieved with a daily intake of:
20 g of olive oil.
This is a robust positive health claim and may be used for a suitable product within the legal requirements.
Its limit, however, is just as clear.
The claim is:
Protection of blood lipids from oxidative stress.
It does not say:
- protects the liver from oxidative stress
- reduces liver fat
- prevents MASLD
- treats MASLD
- improves liver fibrosis
This distinction is both scientifically and legally crucial for Green Agora.
20 g of olive oil per day | Not a medical liver dose
The number:
20 g
is often mentioned in relation to olive oil.
However, its meaning should not be altered.
The daily intake of 20 g is one of the conditions of the approved EU Health Claim for certain olive oil polyphenols.
This does not mean:
20 g of olive oil is a scientifically established treatment for MASLD.
Such a therapeutic olive oil dosage does not exist.
20 g of olive oil provides approximately 180 kilocalories
Olive oil consists almost entirely of fat.
Fat provides approximately:
9 kilocalories per gram.
20 g of olive oil therefore mathematically corresponds to about:
180 kilocalories.
Initially, this is neither positive nor negative.
It is energy.
Especially when weight management is aimed for with MASLD and overweight, this energy should be integrated into the overall diet.
An unfavorable strategy would therefore be:
Leaving the previous diet unchanged and additionally drinking large quantities of olive oil because it supposedly treats the liver.
A high-quality food remains energy-dense.
Use olive oil as a fat source instead of simply drinking it additionally
A more practically sensible consideration is therefore:
Not:
"How much olive oil can I take additionally?"
But:
"Which fat source do I use within my diet?"
Olive oil can, for example, replace other fat sources in the kitchen while being part of a more Mediterranean-oriented diet.
This perspective is much more in line with a dietary pattern than with a treatment with a food item.
The German Nutrition Society also generally recommends plant-based oils and mentions olive oil as a possible fat source.
Does olive oil need to be drunk pure or on an empty stomach for the liver?
No.
There is no convincing human evidence that olive oil exerts a specific liver-related effect in MASLD if it is consumed:
on an empty stomach
or:
as a shot.
Olive oil can quite normally be part of a meal.
For example:
- with vegetables
- in a salad
- with legumes
- with fish
- in Mediterranean dishes
- as a finish
Those who enjoy tasting a high-quality olive oil pure can do so for sensory reasons.
However, a special liver effect of the drinking ritual is not proven.
Drinking olive oil pure | Which varieties are actually suitable
Why extra virgin olive oil can be an interesting choice
If I choose olive oil consciously, I prefer for many applications:
extra virgin olive oil.
It is the highest legal category of virgin olive oils.
This category must meet defined chemical and sensory criteria.
Due to the mechanical or physical extraction, natural minor components are also preserved, which can be strongly altered or largely removed during refining.
This makes extra virgin olive oil particularly interesting both sensorially and analytically.
However, this does not give rise to a liver-specific promise of efficacy.
EVOO remains a high-quality food product and not a drug for MASLD.
Is a high-phenolic EVOO automatically better for MASLD?
A high polyphenol content can be a very interesting analytical property of an olive oil.
Phenolic compounds are being studied intensively and can be relevant for sensory qualities, stability, and certain authorized health claims.
Human studies also compare oils with different phenolic profiles.
However, what does not currently follow from this is:
"The higher the total polyphenol value, the more effectively this olive oil treats MASLD."
There is insufficient robust direct clinical evidence for such a dose-response claim.
Therefore, an olive oil with exceptional analytical values should be appreciated for exactly that:
as an analytically exceptional olive oil.
Not as an unproven liver therapeutic.
Why Pamako does not need to be a "liver oil"
Based on its actual product characteristics, Pamako can be an exceptionally interesting olive oil.
These include, for example:
- the Tsounati olive variety
- its origin
- the production method
- its intense sensory character
- available product-specific analyses
- its phenolic profile
We are allowed to and should clearly communicate these properties.
What should not arise from this is a statement like:
"Pamako is especially good for people with fatty liver."
or:
"Pamako reduces MASLD."
There is no corresponding clinical proof or authorized health claim for such product-specific disease effects.
A premium olive oil does not become less valuable just because we do not attribute a medical treatment to it.
Origin, olive variety, sensory profile, production, and transparent analysis are already strong arguments.
Why historical analysis values always require context
Olive oil is a natural product.
Analysis values can differ based on:
- Product
- Harvest
- Batch
- Processing
- Storage
- Analysis method
- Analysis date
Therefore, at Green Agora, the rule is:
Product | Harvest | Batch | Analysis | Method | Date.
An exceptional historical analysis value may be correct and interesting for that specific sample at that time.
However, it should not automatically be presented as an unchangeable property of every subsequent harvest.
Current product-specific analysis is stronger than a historical promise carried forward indefinitely.
What about insulin sensitivity?
Insulin resistance is closely linked to MASLD and other cardiometabolic changes.
This is why research into the Mediterranean diet, EVOO, and metabolic parameters is also interesting for this field of study.
Randomized studies and meta-analyses examine, among other things:
- Insulin
- HOMA-IR
- Glucose
- Blood lipids
- Blood pressure
- Body weight
Positive changes in a metabolic marker can be scientifically relevant.
However, they are not automatically equivalent to a proven treatment for MASLD.
Metabolic effects and liver-specific disease effects are different endpoints.
Oxidative stress | Where the legal boundary is particularly important
Phenolic compounds from olive oil are being studied intensively in connection with oxidative processes.
For certain olive oil polyphenols, the aforementioned authorized EU Health Claim actually exists.
This is precisely where linguistic precision is particularly important.
From:
"Olive oil polyphenols contribute to the protection of blood lipids from oxidative stress."
we must not turn it into:
"Olive oil protects the liver from oxidative stress."
The authorized claim mentions:
Blood lipids.
Not liver cells.
Green Agora sticks strictly to this authorized statement.
Olive oil alone or the Mediterranean diet | Two different research questions
Many supposed contradictions arise because different types of studies are mixed together.
One study compares:
Olive oil with another oil.
Another:
The Mediterranean diet with a low-fat diet.
Another:
Weight loss with additional olive oil intervention.
And another:
High-phenolic with lower-phenolic olive oil.
These are different research questions.
Scientific evidence for a Mediterranean dietary pattern cannot, therefore, be automatically transferred to every single bottle of premium olive oil.
Conversely, positive results from a specific olive oil study must not be treated as if they were meaningless.
The decisive factors are always:
Population | Product | Dose | Duration | Control group | Dietary context | Endpoint.
What does this mean in practice for MASLD?
With a diagnosis of MASLD, nutrition should not be reduced to the search for a "best liver oil."
According to current guidelines, depending on the individual situation, this especially includes:
- Improving overall dietary quality
- In cases of overweight, sustainable weight management
- Regular physical activity
- Fewer ultra-processed foods
- Avoiding or reducing sugar-sweetened beverages
- High-quality fat sources
- A plant-focused food selection
- Treatment of diabetes, high blood pressure, and lipid metabolism disorders
- Medical assessment of fibrosis risk
Olive oil can be a high-quality fat source within this system.
But it remains:
a building block within a larger overall picture.
A sensible way to integrate olive oil into the diet
Use olive oil as a fat source
Olive oil can be sensibly integrated into meals instead of automatically consuming it in addition to existing fat sources.
Combine with plant-focused foods
Olive oil pairs particularly well with, for example:
- Vegetables
- Legumes
- Salads
- Whole grain products
- Fish
- Mediterranean dishes
Use taste as an advantage
A good olive oil can make simple plant-based foods more appetizing.
This is a practical culinary advantage that is frequently underestimated.
Incorporate the quantity into the overall diet
Even a high-quality olive oil provides energy and should therefore be part of the total diet.
Do not turn it into a medical treatment
A bottle of olive oil does not replace liver diagnostics or medically necessary treatment.
What role does personal taste play?
For long-term use, taste plays a major role.
Some people love olive oils with:
- Intense bitterness
- Distinct pungency
- Strong green aromas
Others prefer:
- Softer fruitiness
- Less bitterness
- A more harmonious character
If both olive oils are of flawless quality, the analytically most intense product does not automatically have to be the most practical choice.
A high-quality olive oil that is happily and regularly integrated into a balanced kitchen can be more practical than an analytical record-holder that sits unused in the cupboard.
Ayhan's perspective | What I can provide sensible advice on regarding olive oil and the liver
When someone asks me about olive oil and liver health, there is much I can explain sensibly.
You can find more about my work, my selection philosophy, and my role at Green Agora here: Ayhan Çabuk from Green Agora.
I can explain:
- Why olive oil is part of the Mediterranean dietary pattern
- Why the fatty acid profile of olive oil is interesting
- What role Extra Virgin olive oil plays as a quality grade
- What polyphenol and oleocanthal values actually indicate
- Which authorized EU Health Claims exist
- How olive oil can be sensibly used in the kitchen
And of course, I can talk about our products:
- Olive varieties
- Regions
- Producers
- Harvests
- Sensory profile
- Bitterness and pungency
- Analyses
This is strong and honest information.
However, when someone says to me:
"I have been diagnosed with MASLD. Which of your olive oils treats my liver?"
a different level begins.
That is a medical question.
I can explain what role olive oil can play within a Mediterranean dietary pattern and which oil fits the culinary style.
However, I cannot recommend individual liver therapy with a bottle of olive oil.
For me, good advice does not mean saying as little as possible that is positive about olive oil.
It means clearly explaining the actual positive properties and stopping where food knowledge would turn into a medical promise.
Ayhan from Green Agora
Analysis without the human element remains just a number
A high polyphenol value can be very interesting scientifically and analytically.
However, it says nothing about an individual's personal medical situation.
A lab value does not know:
- Diagnosis
- Degree of fibrosis
- Body weight
- Diabetes status
- Blood pressure
- Medications
- Overall diet
- Physical activity
Conversely:
Personal experience is not proof of efficacy.
If someone reports:
"Since I started using this olive oil, my liver values are better."
this does not prove a causal link.
Analysis without the human element remains just a number. Experience without analysis remains just an observation.
Olive oil and MASLD | The biggest myths
| Claim | Scientific classification |
|---|---|
| Olive oil reduces fatty liver. | Too generalized. Individual randomized studies show positive signals, but the overall evidence does not allow for a general therapeutic statement. |
| The more polyphenols, the stronger the liver effect. | Such a dose-response relationship is not sufficiently proven for MASLD in humans. |
| 20 g of olive oil daily treats MASLD. | No. The 20g figure is part of the conditions for the EU Health Claim for certain olive oil polyphenols, among other things. |
| The EU Health Claim says that polyphenols protect the liver. | No. The authorized claim refers explicitly to the protection of blood lipids from oxidative stress. |
| Olive oil must be drunk on an empty stomach. | There is no convincing human evidence for a special liver-specific effect of consumption on an empty stomach. |
| A high-phenolic premium olive oil is automatically better for MASLD. | Not proven. Analytical product quality and therapeutic disease effects are different levels. |
| The calories in olive oil don't matter because it's high-quality. | Even high-quality olive oil provides approximately 9 kcal per gram. When aiming for weight management, the total energy balance is relevant. |
| The Mediterranean diet only works because of olive oil. | No. It is an overall dietary pattern consisting of numerous foods and dietary choices. |
